3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
51
Prostatic Neoplasms
23
Lung Neoplasms
17
Breast Neoplasms
15
Squamous Cell Carcinoma of Head and Neck
13
Stomach Neoplasms
10
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Neoplasms
8
Urinary Bladder Neoplasms
6
Carcinoma, Transitional Cell
6
Triple Negative Breast Neoplasms
5
Non-Muscle Invasive Bladder Neoplasms
5
Neoplasm Metastasis
5
Head and Neck Neoplasms
5
Carcinoma, Squamous Cell
5
Prostatic Neoplasms, Castration-Resistant
4
Ovarian Neoplasms
4
Oropharyngeal Neoplasms
4
Endometrial Neoplasms
4
Small Cell Lung Carcinoma
3
Salivary Gland Neoplasms
3
Nasopharyngeal Carcinoma
3
Laryngeal Neoplasms
3
HER2-positive Breast Cancer
3
Fallopian Tube Neoplasms
3
Anatomic Stage I Breast Cancer AJCC v8
3
Adenocarcinoma
3
Solid Tumors
2
Sarcoma
2
Osteosarcoma
2
Interventions
enzalutamide
3
inavolisib
1
abiraterone
1
PF06821497
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metastatic Castration-Resistant Prostate Cancer
×
Docetaxel
×
90 days
×
Clear all
NCT07287150
2026-05-06
InavoPC
Hoffmann-La Roche
Phase 2
Recruiting
100 enrolled